Ishaan Ashwini Tewarie1,2,3, Charissa A C Jessurun1,2,3, Alexander F C Hulsbergen1,2,3, Timothy R Smith1, Rania A Mekary1,4, Marike L D Broekman1,2,3,5. 1. Department of Neurosurgery, Computational Neuroscience Outcomes Center (CNOC), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. 2. Department of Neurosurgery, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands. 3. Department of Neurosurgery, Haaglanden Medical Center, The Hague, Zuid-Holland, the Netherlands. 4. Department of Pharmaceutical Business and Administrative Sciences, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA. 5. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Leptomeningeal disease (LMD) is a complication distinguished by progression of metastatic disease into the leptomeninges and subsequent spread via cerebrospinal fluid (CSF). Although treatments for LMD exist, it is considered fatal with a median survival of 2-4 months. A broader overview of the risk factors that increase the brain metastasis (BM) patient's risk of LMD is needed. This meta-analysis aimed to systematically review and quantitatively assess risk factors for LMD after surgical resection for BM. METHODS: A systematic literature search was performed on 7 May 2021. Pooled effect sizes were calculated using a random-effects model for variables reported by three or more studies. RESULTS: Among 503 studies, thirteen studies met the inclusion criteria with a total surgical sample size of 2105 patients, of which 386 patients developed LMD. The median incidence of LMD across included studies was 16.1%. Eighteen unique risk factors were reported as significantly associated with LMD occurrence, including but not limited to: larger tumor size, infratentorial BM location, proximity of BM to cerebrospinal fluid spaces, ventricle violation during surgery, subtotal or piecemeal resection, and postoperative stereotactic radiosurgery. Pooled results demonstrated that breast cancer as the primary tumor location (HR = 2.73, 95% CI: 2.12-3.52) and multiple BMs (HR = 1.37, 95% CI: 1.18-1.58) were significantly associated with a higher risk of LMD occurrence. CONCLUSION: Breast cancer origin and multiple BMs increase the risk of LMD occurrence after neurosurgery. Several other risk factors which might play a role in LMD development were also identified.
BACKGROUND: Leptomeningeal disease (LMD) is a complication distinguished by progression of metastatic disease into the leptomeninges and subsequent spread via cerebrospinal fluid (CSF). Although treatments for LMD exist, it is considered fatal with a median survival of 2-4 months. A broader overview of the risk factors that increase the brain metastasis (BM) patient's risk of LMD is needed. This meta-analysis aimed to systematically review and quantitatively assess risk factors for LMD after surgical resection for BM. METHODS: A systematic literature search was performed on 7 May 2021. Pooled effect sizes were calculated using a random-effects model for variables reported by three or more studies. RESULTS: Among 503 studies, thirteen studies met the inclusion criteria with a total surgical sample size of 2105 patients, of which 386 patients developed LMD. The median incidence of LMD across included studies was 16.1%. Eighteen unique risk factors were reported as significantly associated with LMD occurrence, including but not limited to: larger tumor size, infratentorial BM location, proximity of BM to cerebrospinal fluid spaces, ventricle violation during surgery, subtotal or piecemeal resection, and postoperative stereotactic radiosurgery. Pooled results demonstrated that breast cancer as the primary tumor location (HR = 2.73, 95% CI: 2.12-3.52) and multiple BMs (HR = 1.37, 95% CI: 1.18-1.58) were significantly associated with a higher risk of LMD occurrence. CONCLUSION: Breast cancer origin and multiple BMs increase the risk of LMD occurrence after neurosurgery. Several other risk factors which might play a role in LMD development were also identified.
Authors: Eric Ojerholm; John Y K Lee; Jayesh P Thawani; Denise Miller; Donald M O'Rourke; Jay F Dorsey; Geoffrey A Geiger; Suneel Nagda; James D Kolker; Robert A Lustig; Michelle Alonso-Basanta Journal: J Neurosurg Date: 2014-12 Impact factor: 5.115
Authors: Jason Hsieh; Paul Elson; Balint Otvos; Jonathan Rose; Christopher Loftus; Gazanfar Rahmathulla; Lilyana Angelov; Gene H Barnett; Robert J Weil; Michael A Vogelbaum Journal: Neurosurgery Date: 2015-04 Impact factor: 4.654
Authors: Aki Morikawa; Lilly Jordan; Raquel Rozner; Sujata Patil; Adrienne Boire; Elena Pentsova; Andrew D Seidman Journal: Clin Breast Cancer Date: 2016-07-25 Impact factor: 3.225
Authors: Vitaly E Siomin; Michael A Vogelbaum; Andrew A Kanner; Shih-Yuan Lee; John H Suh; Gene H Barnett Journal: J Neurooncol Date: 2004 Mar-Apr Impact factor: 4.130
Authors: Siyu Shi; Navjot Sandhu; Michael C Jin; Elyn Wang; Joseph Abi Jaoude; Kirsten Schofield; Carrie Zhang; Elisa Liu; Iris C Gibbs; Steven L Hancock; Steven D Chang; Gordon Li; Melanie Hayden-Gephart; John R Adler; Scott G Soltys; Erqi L Pollom Journal: Int J Radiat Oncol Biol Phys Date: 2019-11-27 Impact factor: 7.038
Authors: Robert H Press; Chao Zhang; Mudit Chowdhary; Roshan S Prabhu; Matthew J Ferris; Karen M Xu; Jeffrey J Olson; Bree R Eaton; Hui-Kuo G Shu; Walter J Curran; Ian R Crocker; Kirtesh R Patel Journal: Neurosurgery Date: 2019-11-01 Impact factor: 4.654
Authors: Daniel N Cagney; Nayan Lamba; Sumi Sinha; Paul J Catalano; Wenya Linda Bi; Brian M Alexander; Ayal A Aizer Journal: JAMA Oncol Date: 2019-05-01 Impact factor: 31.777
Authors: Andrew J Huang; Karen E Huang; Brandi R Page; Diandra N Ayala-Peacock; John T Lucas; Glenn J Lesser; Adrian W Laxton; Stephen B Tatter; Michael D Chan Journal: J Neurooncol Date: 2014-07-22 Impact factor: 4.130
Authors: Samuel R Marcrom; Paul M Foreman; Tyler B Colvin; Andrew M McDonald; Robert S Kirkland; Richard A Popple; Kristen O Riley; James M Markert; Christopher D Willey; Markus Bredel; John B Fiveash Journal: Adv Radiat Oncol Date: 2019-08-05